Charles River Laboratories International (CRL) Cash on Hand
Market Cap: $7.96B
Avg Volume: 1.15M
Industry: Medical - Diagnostics & Research
Sector: Healthcare
How much cash does Charles River Laboratories International have?
According to Charles River Laboratories International's latest annual financial reports, the company has a total of $194.61M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.
Additionally, Charles River Laboratories International holds $- in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.
In total, the company has $194.61M when combining cash and cash equivalents with short-term investments.
On a per-share basis, Charles River Laboratories International has $3.80 in cash. This metric helps investors understand how much cash the company holds per outstanding share.
The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $501.61M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.
Lastly, the company's cash position has experienced a growth rate of -29.69%, reflecting the increase in cash and cash equivalents over the specified period.
Cash & Cash Equivalents
$194.61M
Short-Term Investments
$-
Cash & Short-Term Investments
$194.61M
Cash Per Share
$3.80
Free Cash Flow
$501.61M
Cash Growth
-29.69%
Charles River Laboratories International Historical Cash on Hand
Cash on Hand History
The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2024.
| Year | Cash on Hand | Change |
|---|---|---|
| 2024 | $194.61M | -29.69% |
| 2023 | $276.77M | 18.32% |
| 2022 | $233.91M | -3.03% |
| 2021 | $241.21M | 5.60% |
| 2020 | $228.42M | -4.03% |
| 2019 | $238.01M | 21.78% |
| 2018 | $195.44M | 19.32% |
| 2017 | $163.79M | 39.25% |
| 2016 | $117.63M | -0.27% |
| 2015 | $117.95M | -26.29% |
| 2014 | $160.02M | 2.63% |
| 2013 | $155.93M | 42.16% |
| 2012 | $109.69M | 59.18% |
| 2011 | $68.91M | -61.54% |
| 2010 | $179.16M | -1.87% |
| 2009 | $182.57M | -25.05% |
| 2008 | $243.59M | 8.05% |
| 2007 | $225.45M | 28.55% |
| 2006 | $175.38M | 52.74% |
| 2005 | $114.82M | -44.68% |
| 2004 | $207.57M | 13.84% |
| 2003 | $182.33M | 48.83% |
| 2002 | $122.51M | 110.24% |
| 2001 | $58.27M | 75.89% |
| 2000 | $33.13M | 120.71% |
| 1999 | $15.01M | -39.50% |
| 1998 | $24.81M | N/A |
Related Metrics
Explore detailed financial metrics and analysis for CRL.